EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer

被引：0
|
作者：
Giuseppe Giaccone
机构：
[1] Head of the Department of Medical Oncology of the Free University Medical Center,
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：296 / 297
页数：1
相关论文
共 50 条
  • [21] Effect of EGFR mutations on gefitinib in advanced previous treated non-small-cell lung cancer
    Guo, J.
    Zhou, C.
    Deng, Q.
    Ren, S.
    Zhang, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] EGFR mutation and non-small-cell lung cancer: EGFR test, cost and quality of life
    Thongprasert, Sumitra
    [J]. LUNG CANCER MANAGEMENT, 2012, 1 (03) : 169 - 172
  • [23] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Kejun Liu
    Guanming Jiang
    Ailing Zhang
    Zhuanghua Li
    Jun Jia
    [J]. BMC Cancer, 20
  • [24] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Liu, Kejun
    Jiang, Guanming
    Zhang, Ailing
    Li, Zhuanghua
    Jia, Jun
    [J]. BMC CANCER, 2020, 20 (01)
  • [25] The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer
    Zhang, XT
    Li, LY
    Mu, XL
    Cui, QC
    Chang, XY
    Song, W
    Wang, SL
    Wang, MZ
    Zhong, W
    Zhang, L
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (08) : 1334 - 1342
  • [26] Mutation-specific antibodies for the detection of EGFR mutation in non-small-cell lung cancer
    Yu, Jian
    Kane, Susan
    Li, Daigiang
    Benedettini, Elisa
    Haack, Herbert
    Smith, Bradly
    Gu, Tinglei
    Loda, Massimo
    Zhou, Xinmine
    Comb, Michael
    [J]. CANCER RESEARCH, 2009, 69
  • [27] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [28] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    [J]. LANCET, 2006, 367 (9507): : 299 - 300
  • [29] Biomarkers of response to gefitinib in non-small-cell lung cancer
    Carbone, David P.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 66 - 67
  • [30] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer REPLY
    Cataldo, Vince D.
    Gibbons, Don L.
    Quintas-Cardama, Alfonso
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2368 - 2368
12345